Federal contract award
HQ085926FF072
SCALABLE HOMELAND INNOVATIVE ENTERPRISE LAYERED DEFENSE (SHIELD) INITIAL ORDER.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | MISSILE DEFENSE AGENCY (MDA) |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AC13 — NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | HQ085926DE826 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | $0 |
| Potential contract value / ceiling | $0 |
| Start date | Dec 29, 2025 |
| Current end date | Feb 27, 2026 |
| Potential end date | Feb 27, 2026 |
| Latest award activity | Mar 4, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 4, 2026 | P00001 | $-500 | SCALABLE HOMELAND INNOVATIVE ENTERPRISE LAYERED DEFENSE (SHIELD) INITIAL ORDER. |
| Dec 5, 2025 | 0 | $500 | SCALABLE HOMELAND INNOVATIVE ENTERPRISE LAYERED DEFENSE (SHIELD) INITIAL ORDER. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| SHIELD IDIQ Team | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Jan 15, 2026 |
| SHIELD IDIQ Team | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Dec 18, 2025 |
| SHIELD IDIQ Team | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Dec 2, 2025 |
| SHIELD IDIQ Team | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Nov 20, 2025 |
| SHIELD IDIQ Team | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Oct 7, 2025 |
| SHIELD IDIQ Team | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Oct 6, 2025 |
| SHIELD IDIQ Team | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Oct 3, 2025 |
| SHIELD IDIQ Team | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Oct 2, 2025 |
| SHIELD IDIQ Team | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Sep 18, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Sep 11, 2025 |
| SHIELD IDIQ Team | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Sep 10, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Aug 8, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Jul 30, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Jul 30, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Jul 25, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Jul 24, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | Jul 3, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | May 22, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | May 22, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | May 22, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | May 22, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | May 21, 2025 |
| MDA SHIELD IDIQ | Contact | mda.schriever.cts.mbx.shield-idiq@mail.mil | Source | May 21, 2025 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.